4.5 Article

Mannan-binding lectin ameliorates renal fibrosis by suppressing macrophage-to-myofibroblast transition

期刊

HELIYON
卷 9, 期 11, 页码 -

出版社

CELL PRESS
DOI: 10.1016/j.heliyon.2023.e21882

关键词

Mannan-binding lectin; Renal fibrosis; Macrophages; Myofibroblasts

向作者/读者索取更多资源

MBL deficiency worsens renal fibrosis in a chronic kidney disease mouse model, and macrophages play a crucial role in MBL-mediated suppression of renal fibrosis. MBL inhibits macrophage-to-myofibroblast transition by suppressing matrix metalloproteinase 9 production and Akt signaling activation.
Mannan-binding lectin (MBL) is a pattern-recognition molecule that plays a crucial role in innate immunity. MBL deficiency correlates with an increased risk of chronic kidney disease (CKD). However, the molecular mechanisms are not fully defined. Here, we established a CKD model in wild-type (WT) and MBL-deficient (MBL-/- ) mice via unilateral ureteral obstruction (UUO). The result showed that MBL deficiency aggravated the pathogenesis of renal fibrosis in CKD mice. Strikingly, the in vivo macrophage depletion investigation revealed that macrophages play an essential role in the MBL-mediated suppression of renal fibrosis. We found that MBL limited the progression of macrophage-to-myofibroblast transition (MMT) in kidney tissues of UUO mice. Further in vitro study showed that MBL- /- macrophages exhibited significantly increased levels of fibrotic-related molecules compared with WT cells upon transforming growth factor beta (TGF-beta) stimulation. We demonstrated that MBL inhibited the MMT process by suppressing the production of matrix metalloproteinase 9 (MMP-9) and activation of Akt signaling. In summary, our study revealed an expected role of MBL on macrophage transition during renal fibrosis, thus offering new insight into the potential of MBL as a therapeutic target for CKD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据